These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2157182)

  • 1. c-fos mediated stimulation of an AP-1 DNA binding activity in undifferentiated teratocarcinoma cell lines.
    Caceres J; Glikin G; Bravo R; Weinmann R
    Oncogene; 1990 Jan; 5(1):59-67. PubMed ID: 2157182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
    Chuĭkin IA; Lianguzova MS; Pospelov VA
    Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of jun and fos genes during differentiation of mouse P19 embryonal carcinoma cells.
    de Groot RP; Schoorlemmer J; van Genesen ST; Kruijer W
    Nucleic Acids Res; 1990 Jun; 18(11):3195-202. PubMed ID: 2113273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A direct role for c-fos in AP-1-dependent gene transcription.
    Herrera R; Agarwal S; Walton K; Satterberg B; Distel RJ; Goodman R; Spiegelman BM; Roberts TM
    Cell Growth Differ; 1990 Oct; 1(10):483-90. PubMed ID: 2126190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of an intron enhancer within the keratin 18 gene by expression of c-fos and c-jun in undifferentiated F9 embryonal carcinoma cells.
    Oshima RG; Abrams L; Kulesh D
    Genes Dev; 1990 May; 4(5):835-48. PubMed ID: 1696235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-binding activity of Jun is increased through its interaction with Fos.
    Allegretto EA; Smeal T; Angel P; Spiegelman BM; Karin M
    J Cell Biochem; 1990 Apr; 42(4):193-206. PubMed ID: 2111328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
    Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
    Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation and inhibition of the AP-1 complex in human breast cancer cells.
    Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
    Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultraviolet irradiation, although it activates the transcription factor AP-1 in F9 teratocarcinoma stem cells, does not induce the full complement of differentiation-associated genes.
    Auer HP; König H; Litfin M; Stein B; Rahmsdorf HJ
    Exp Cell Res; 1994 Sep; 214(1):131-8. PubMed ID: 7521841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of AP-1/DNA complex formation in vitro.
    Frame MC; Wilkie NM; Darling AJ; Chudleigh A; Pintzas A; Lang JC; Gillespie DA
    Oncogene; 1991 Feb; 6(2):205-9. PubMed ID: 1900354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins.
    Ryseck RP; Bravo R
    Oncogene; 1991 Apr; 6(4):533-42. PubMed ID: 1827665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK.
    Deng T; Karin M
    Nature; 1994 Sep; 371(6493):171-5. PubMed ID: 8072547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The embryonal carcinoma stem cell Ela-like activity involves a differentiation-regulated transcription factor.
    La Thangue NB; Thimmappaya B; Rigby PW
    Nucleic Acids Res; 1990 May; 18(10):2929-38. PubMed ID: 2140887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K; Colburn NH
    Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
    Manna PR; Eubank DW; Stocco DM
    Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive regulation of jun/AP-1 by E1A.
    de Groot R; Foulkes N; Mulder M; Kruijer W; Sassone-Corsi P
    Mol Cell Biol; 1991 Jan; 11(1):192-201. PubMed ID: 1824713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of AP1 activity during F9 cell differentiation is due to increased c-jun transcription.
    Yang-Yen HF; Chiu R; Karin M
    New Biol; 1990 Apr; 2(4):351-61. PubMed ID: 1963081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AP-1 (Fos-Jun) regulation by IP-1: effect of signal transduction pathways and cell growth.
    Auwerx J; Sassone-Corsi P
    Oncogene; 1992 Nov; 7(11):2271-80. PubMed ID: 1437149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.